"Clinically studied" can mean a rigorous 180-day placebo-controlled trial — or it can mean a brand once handed the powder to twelve people for a week. The phrase itself is doing almost no work. Here's how to tell the difference, so you never overpay for a claim that evaporates under one question. For the bigger picture on evaluating joint products, start with joint discomfort after 40.
The phrase is not regulated the way you think
"Clinically studied" is not a certification. There is no minimum bar a product must clear to print it. It simply implies that some study, somewhere, involved the ingredient. It does not tell you whether the study was any good, whether it used the same dose as the product, or whether it even found anything.
The five questions that expose a weak claim
- Was there a placebo group? Without one, you can't separate the ingredient's effect from natural variation and the placebo response. "Everyone felt better" is not evidence.
- Was it randomized and blinded? These controls stop the researchers' and participants' expectations from skewing the result.
- How long did it run? A one-week study can't speak to a process that takes months, like joint comfort.
- What was measured — and did the main measure hit? A validated instrument (like the WOMAC joint index) is data; a vague satisfaction survey is not. And researchers name their main question before the study begins, so if that pre-registered primary measure missed, a good-looking secondary number doesn't replace it.
- Does the product dose match the study dose? This is the one brands hide most. A study on 20 mg is meaningless if the capsule contains 2 mg — a practice sometimes called "fairy dusting."
- Who paid for it? Sponsor-funded research isn't automatically wrong, but you deserve to know before you weigh the number.
Running our own evidence through the test
It would be easy to list those questions and then quietly skip them. So here is the cucumber extract we sell, put through its own five questions.
Q-Actin® was studied in a 180-day randomized, double-blind trial in which the 20 mg dose improved WOMAC scores by 70.3% versus 33.7% for glucosamine-chondroitin (Nash et al., 2018, PMC6207263). Applying the test to it:
- Placebo group? No. Both arms took an active supplement, so it shows how the two compared with each other — not how either compares with taking nothing.
- Randomized and blinded? Yes.
- Long enough? Yes — 180 days suits a slow process.
- Validated measure? Yes — the WOMAC index.
- Dose match? Yes — 20 mg studied, 20 mg in the product.
- Who paid? The sponsor.
A second, 60-day study reported a 31.79% WOMAC improvement from baseline — a within-group change — and its pre-registered primary measure did not reach statistical significance (Hausenblas et al., 2025). It had a placebo group; it did not produce a significant primary result.
What the research says
That is a mixed scorecard, and publishing it is the point. Two of the five questions land awkwardly for our own evidence, and you would have found that out in ten minutes with the citations we just gave you. The test isn't whether a brand says "clinically studied" — it's whether they hand you the paper and let you mark it yourself.
The "proprietary blend" red flag
If a label lists a "proprietary blend" with a single total weight but won't break down the dose of each ingredient, you cannot verify the dose against any study. That's not proprietary science — it's a way to include a "fairy dusting" of the studied ingredient while implying the full clinical dose.
How to actually check
Ask the brand for the citation — a real PubMed or PMC ID, not a stock-photo "lab." Then look it up. Does the study match the product's dose? Was it placebo-controlled? Did the primary measure hit? Did the ad's promise survive the paper? A brand confident in its evidence will point you straight to the study. A brand that won't is telling you something.
This is why our joint supplement lists its studies on PubMed and doses to match them. If you want to know how to read the joint-score data specifically, see WOMAC scores explained, or compare the two main options in Q-Actin® vs glucosamine.
Frequently Asked Questions
Does "clinically studied" mean the product works?
No. It only implies a study involving the ingredient exists. It says nothing about the study's quality, dose match, funding, or findings. Ask for the citation and check it.
What is "fairy dusting"?
Including a tiny amount of a studied ingredient — far below the clinically studied dose — so the label can claim it while the product can't realistically replicate the study's result.
How do I verify a supplement's claim myself?
Ask for the specific study (a PubMed or PMC ID), look it up, and check five things: was it placebo-controlled, was it randomized and blinded, how long did it run, did the pre-registered primary measure reach significance, and does the product's dose match the dose tested.
Written by Dr. Mohammed Hawa, DHA, Founder of VyVa.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before beginning any supplement, particularly if you are pregnant, breastfeeding, under 18, or taking prescription medication.
